The Pharmacy Times® Attention-Deficit Hyperactivity Disorder (ADHD) Resource Center is a comprehensive resource for clinical news and expert insights on issues related to ADHD, a chronic condition that can cause attention difficulty, hyperactivity, and impulsiveness.
October 29th 2024
Evolving understanding of attention deficit hyperactivity disorder (ADHD) underscores the need for inclusive research and support, especially for women.
ADHD Patients More Likely to Augment Meds After Receiving Atypical Antipsychotics
January 3rd 2015Stimulant-treated adolescents with attention deficit hyperactivity disorder who switch to atypical antipsychotics show significantly greater drug augmentation, health care resource utilization, and costs compared with their counterparts who switch to nonantipsychotics.
Read More
Vyvanse Receives FDA Priority Review for Expanded Binge Eating Disorder Indication
September 16th 2014The FDA has granted priority review to a supplemental New Drug Application that would expand the use of lisdexamfetamine dimesylate (Vyvanse) to treat adult patients with binge eating disorder.
Read More